Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. (Q35605949)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 August 2011

Language	Label	Description	Also known as
English	Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.	scientific article published on 25 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jeffrey Rubnitz

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Monika L Metzger

6

object named as

Monika L Metzger

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Hiroto Inaba

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jennifer L Pauley

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Deqing Pei

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Cheng Cheng

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Scott C Howard

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

John T Sandlund

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Raul C Ribeiro

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Wing Leung

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Dario Campana

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sima Jeha

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ching-Hon Pui

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

0 references

publication date

25 August 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

British Journal of Haematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

156

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

275-279

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08847.X

21 January 2018

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08847.X

21 January 2018

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08847.X

21 January 2018

Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08847.X

21 January 2018

Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08847.X

21 January 2018

DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235268

25 September 2018

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21883141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21883141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2011.08847.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21883141%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35605949&oldid=1645059241"